Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

DORAL

QUAZEPAM

Standard Dose
15MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview DORAL is listed in Drugs@FDA under application 018708 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient QUAZEPAM Form and strength TABLET;ORAL - 15MG Sponsor GALT PHARMS Submission history Latest submission status date: 2023-01-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview DORAL is listed in Drugs@FDA under application 018708 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient QUAZEPAM Form and strength TABLET;ORAL - 15MG Sponsor GALT PHARMS Submission history Latest submission status date: 2023-01-13 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.